Literature DB >> 26451963

Standard of Care for Neuropsychological Monitoring in Pediatric Neuro-Oncology: Lessons From the Children's Oncology Group (COG).

Karin S Walsh1, Robert B Noll2, Robert D Annett3, Sunita K Patel4, Andrea F Patenaude5, Leanne Embry6.   

Abstract

As the mortality of pediatric cancers has decreased, focus on neuropsychological morbidities of treatment sequelae have increased. Neuropsychological evaluations are essential diagnostic tools that assess cognitive functioning and neurobiological integrity. These tests provide vital information to support ongoing medical care, documenting cognitive morbidity and response to interventions. We frame standards for neuropsychological monitoring of pediatric patients with CNS malignancy or who received cancer-directed therapies involving the CNS and discuss billing for these services in the United States in the context of clinical research. We describe a cost-effective, efficient model of neuropsychological monitoring that may increases access to neuropsychological care.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  late effects; pediatric oncology; psychology

Mesh:

Year:  2015        PMID: 26451963      PMCID: PMC5222571          DOI: 10.1002/pbc.25759

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  28 in total

Review 1.  Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group.

Authors:  Paul C Nathan; Sunita K Patel; Kimberley Dilley; Robert Goldsby; Jeanne Harvey; Chad Jacobsen; Nina Kadan-Lottick; Karen McKinley; Anne K Millham; Ida Moore; M Fatih Okcu; Catherine L Woodman; Pim Brouwers; F Daniel Armstrong
Journal:  Arch Pediatr Adolesc Med       Date:  2007-08

Review 2.  Neurocognitive effects of treatment for childhood cancer.

Authors:  Robert W Butler; Jennifer K Haser
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2006

3.  Implementation of multi-site neurocognitive assessments within a pediatric cooperative group: can it be done?

Authors:  Leanne Embry; Robert D Annett; Alicia Kunin-Batson; Sunita K Patel; Stephen Sands; Gregory Reaman; Robert B Noll
Journal:  Pediatr Blood Cancer       Date:  2012-05-03       Impact factor: 3.167

Review 4.  Acute lymphoblastic leukemia: long-term psychological outcome.

Authors:  R K Mulhern; A G Friedman; P A Stone
Journal:  Biomed Pharmacother       Date:  1988       Impact factor: 6.529

5.  CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory.

Authors:  Thorsten Langer; Peter Martus; Holger Ottensmeier; Holger Hertzberg; Jörn D Beck; Walburga Meier
Journal:  Med Pediatr Oncol       Date:  2002-05

6.  Neurocognitive, functional, and health outcomes at 5 years of age for children after complex cardiac surgery at 6 weeks of age or younger.

Authors:  Dianne E Creighton; Charlene M T Robertson; Reg S Sauve; Diane M Moddemann; Gwen Y Alton; Alberto Nettel-Aguirre; David B Ross; Ivan M Rebeyka
Journal:  Pediatrics       Date:  2007-09       Impact factor: 7.124

Review 7.  Late neurocognitive sequelae in survivors of brain tumours in childhood.

Authors:  Raymond K Mulhern; Thomas E Merchant; Amar Gajjar; Wilburn E Reddick; Larry E Kun
Journal:  Lancet Oncol       Date:  2004-07       Impact factor: 41.316

8.  Communication of randomization in childhood leukemia trials.

Authors:  Eric Kodish; Michelle Eder; Robert B Noll; Kathleen Ruccione; Beverly Lange; Anne Angiolillo; Rebecca Pentz; Stephen Zyzanski; Laura A Siminoff; Dennis Drotar
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

9.  Screening for neurocognitive impairment in pediatric cancer long-term survivors.

Authors:  Kevin R Krull; M Fatih Okcu; Brian Potter; Neelam Jain; ZoAnn Dreyer; Kala Kamdar; Pim Brouwers
Journal:  J Clin Oncol       Date:  2008-09-01       Impact factor: 44.544

10.  Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study.

Authors:  Gregory T Armstrong; Qi Liu; Yutaka Yasui; Sujuan Huang; Kirsten K Ness; Wendy Leisenring; Melissa M Hudson; Sarah S Donaldson; Allison A King; Marilyn Stovall; Kevin R Krull; Leslie L Robison; Roger J Packer
Journal:  J Natl Cancer Inst       Date:  2009-06-17       Impact factor: 11.816

View more
  13 in total

1.  The Behavior Rating Inventory of Executive Function (BRIEF) to Identify Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors At Risk for Neurocognitive Impairment.

Authors:  Adrienne Viola; Lyn Balsamo; Joseph P Neglia; Pim Brouwers; Xiaomei Ma; Nina S Kadan-Lottick
Journal:  J Pediatr Hematol Oncol       Date:  2017-04       Impact factor: 1.289

2.  Parent-reported cognitive function is associated with leukoencephalopathy in children with brain tumors.

Authors:  Jin-Shei Lai; Corey Bregman; Frank Zelko; Cindy Nowinski; David Cella; Jennifer J Beaumont; Stewart Goldman
Journal:  Qual Life Res       Date:  2017-04-26       Impact factor: 4.147

3.  Neurocognitive functioning in long-term survivors of pediatric hematopoietic cell transplantation.

Authors:  Kendra R Parris; Kathryn M Russell; Brandon M Triplett; Sean Phipps
Journal:  Bone Marrow Transplant       Date:  2020-11-14       Impact factor: 5.483

4.  Difficulties encountered by physicians and mental health professionals in evaluating and caring for affective and behavioral problems in pediatric brain tumor survivors.

Authors:  Clémentine Lopez; Serge Sultan; Kristopher Lamore; Christelle Dufour; Estelle Favré; Léonor Fasse; Cécile Flahault
Journal:  Support Care Cancer       Date:  2021-05-14       Impact factor: 3.603

5.  Neurocognitive, academic and functional outcomes in survivors of infant ependymoma (UKCCSG CNS 9204).

Authors:  Matthew C H J Morrall; Rosa Reed-Berendt; Kate Moss; Helen Stocks; Alexandra L Houston; Poppy Siddell; Susan Picton; Richard Grundy
Journal:  Childs Nerv Syst       Date:  2018-12-15       Impact factor: 1.475

Review 6.  Neurocognitive Outcomes and Interventions in Long-Term Survivors of Childhood Cancer.

Authors:  Kevin R Krull; Kristina K Hardy; Lisa S Kahalley; Ilse Schuitema; Shelli R Kesler
Journal:  J Clin Oncol       Date:  2018-06-06       Impact factor: 44.544

7.  Proton Beam Radiation Therapy: The Future May Prove Brighter for Pediatric Patients With Brain Tumors.

Authors:  Stephen A Sands
Journal:  J Clin Oncol       Date:  2016-01-25       Impact factor: 44.544

8.  Computerized assessment of cognitive impairment among children undergoing radiation therapy for medulloblastoma.

Authors:  Andrew M Heitzer; Jason M Ashford; Brian T Harel; Adrian Schembri; Michelle A Swain; Joanna Wallace; Kirsten K Ness; Fang Wang; Hui Zhang; Thomas E Merchant; Giles W Robinson; Amar Gajjar; Heather M Conklin
Journal:  J Neurooncol       Date:  2018-11-22       Impact factor: 4.130

9.  Do we still need IQ-scores? Misleading interpretations of neurocognitive outcome in pediatric patients with medulloblastoma: a retrospective study.

Authors:  Barbara Wegenschimmel; Ulrike Leiss; Michaela Veigl; Verena Rosenmayr; Anton Formann; Irene Slavc; Thomas Pletschko
Journal:  J Neurooncol       Date:  2017-08-04       Impact factor: 4.130

10.  Long-term cognitive deficits in pediatric low-grade glioma (LGG) survivors reflect pretreatment conditions-report from the German LGG studies.

Authors:  Thomas Traunwieser; Daniela Kandels; Franz Pauls; Torsten Pietsch; Monika Warmuth-Metz; Brigitte Bison; Juergen Krauss; Rolf-Dieter Kortmann; Beate Timmermann; Ulrich-Wilhelm Thomale; Peggy Luettich; Anne Neumann-Holbeck; Tanja Tischler; Pablo Hernáiz Driever; Olaf Witt; Astrid K Gnekow
Journal:  Neurooncol Adv       Date:  2020-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.